Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
about
Serenoa repens for benign prostatic hyperplasiaSerenoa repens for benign prostatic hyperplasiaAcupuncture for benign prostatic hyperplasia: a systematic review protocolCustom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.Determinants of male reproductive health disorders: the Men in Australia Telephone Survey (MATeS).Effects of running distance and performance on incident benign prostatic hyperplasiaSmoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse modelIntensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial.Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.Possible mechanism of benign prostatic hyperplasia induced by androgen-estrogen ratios in castrated ratsThe correlation between the treatment efficacy and the sympathetic activity in men with lower urinary tract symptomsThe study about physical activity for subjects with prevention of benign prostate hyperplasia.Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey.Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Physical activity and benign prostatic hyperplasia-related outcomes and nocturiaComparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP.Chemokines and BPH/LUTSMetabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.Lower urinary tract symptoms in men.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational StudyRelationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study.Association of Alcohol Consumption with Markers of Prostate Health and Reproductive Hormone Profiles: A Multi-Center Study of 4,535 Men in ChinaObesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort StudyDiabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients?Urologic disease burden in the United States: veteran users of Department of Veterans Affairs healthcare.Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.Alcohol, Smoking, Physical Activity, Protein, and Lower Urinary Tract Symptoms: Prospective Longitudinal Cohort.Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP)Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States menAssociation between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.
P2860
Q24202555-BF5FE0C0-C0E2-4CAA-AA26-B75390E7E9A1Q24241144-5705985E-4F4D-40A3-99F3-7756F72E4532Q26861159-D99C61EF-4313-4C3E-869E-85E445ED217AQ28547212-17010040-0956-49D7-96E1-0D72825DB640Q30432283-97B85621-C159-452F-8ED3-E1E633FF31DCQ33534054-27E7F484-BEFC-4221-BB5A-3835D4E614E9Q33687735-7D1046F6-A07E-4C24-A8BB-D146D97C3118Q33822388-02B7FE6E-85BD-4BC6-BD62-EADA6C8315D2Q33908275-137E0F87-641C-4C27-AD08-60F0633BCB5CQ34047087-94C1184F-F662-45AC-83CE-A76AED336A01Q34176834-5415C32A-4612-4DCC-A5A7-9824EF18087AQ34222868-825577F0-F803-411F-B95F-19D9136477D8Q34267513-67F076E4-143A-4B50-B823-350334B78DA7Q34267524-7A4B25D9-ED6F-4217-A76A-D76A04BB3D18Q34380392-F5A3B2BB-915D-4A4A-8399-EBFD64D0FB39Q34485215-48098579-1446-4D3C-A13B-50604DEBC6A6Q34591489-1CEA7791-0C9C-4EFE-969E-82C9EE216459Q34962509-63726C15-0504-4F51-9625-1904205FCFEDQ35062696-7A15E6DC-03EA-4117-8538-DBE29D2BCB4AQ35089850-35485641-4951-44DC-890B-603E0333102CQ35126096-57325963-C362-4C06-B1F7-EBB33437E534Q35147535-2CDC12AF-41EC-4BAB-9158-EC8E05F01CE9Q35179438-A00433FE-6971-47CF-9C26-2AF5C8983B9FQ35182377-307AFB58-96A3-4767-AB62-CFCBDD287BDAQ35216293-544768D5-6F7B-4E9F-87EC-9C09E6436372Q35225398-927362FD-D4C1-4D98-804B-C2130A66D605Q35228167-42A1BD03-8E98-42C1-A139-5DE33E480F03Q35813278-D1F813F5-C9AA-413F-BAA3-632E3BF81C7CQ35823776-C6DF6A16-4F2B-4E1A-B86D-83D1640F9D71Q35838637-583B2D8F-E472-4B14-A792-1350817F9A0AQ35891357-6D9AE980-1AA6-403C-9748-F1C1F7DB7AB1Q35927069-32D855AF-54EE-4855-A72D-87CE49B87C68Q35957304-E0E58255-F014-4A4A-994C-27445BDF9FBEQ35993329-61C0E2C5-E8C7-4415-847E-1C2CF4F197AFQ36055324-F0CDC073-A3E1-4FE3-8AAC-45F713A12052Q36081785-F3C50252-68A8-43EF-B99B-E31B93E46A8BQ36090790-46447EFE-A0DF-4963-8891-8E188438D84EQ36161652-0211B6C0-FFA0-4D12-90E5-E15FD57DA690Q36279542-DC9E8385-F90F-429F-B006-53646CB58BE5Q36284900-1D400233-28CA-4A95-A0B8-74A6E986FE91
P2860
Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Risk factors for clinical beni ...... pulation of healthy aging men.
@en
Risk factors for clinical beni ...... pulation of healthy aging men.
@nl
type
label
Risk factors for clinical beni ...... pulation of healthy aging men.
@en
Risk factors for clinical beni ...... pulation of healthy aging men.
@nl
prefLabel
Risk factors for clinical beni ...... pulation of healthy aging men.
@en
Risk factors for clinical beni ...... pulation of healthy aging men.
@nl
P2093
P1476
Risk factors for clinical beni ...... pulation of healthy aging men.
@en
P2093
P304
P356
10.1016/S0895-4356(01)00351-1
P577
2001-09-01T00:00:00Z